Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy. (Q43152906)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2010
edit
Language Label Description Also known as
English
Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy.
scientific article published in February 2010

    Statements

    Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy. (English)
    0 references
    Demir Ozbasar
    Ummuhan Toros
    Okan Ozkaya
    Hafize Uzun
    Habibe Genc
    Hakan Kaya
    1 February 2010
    133-137

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit